Old medications and new targeted therapies in systemic sclerosis
Old medications and new targeted therapies in systemic sclerosis
复制标题
DOI：
10.1093/rheumatology/keu285
复制
发表时间：
2015-11-01
期刊：
影响因子：
5.5
通讯作者：
Khanna, Dinesh
中科院分区：
文献类型：
--
作者：
Nagaraja, Vivek;Denton, Christopher P.;Khanna, Dinesh
SSc是一种多器官疾病，发病率很高，与健康相关的生活质量较差。这种情况的治疗通常是以器官为基础的，而且不能治愈。然而，有更新的、潜在的疾病修改疗法可用于治疗这种疾病的某些方面。本文就临床上治疗SSc的新老疗法作一综述。
SSc is a multiorgan disease with significant morbidity that is associated with poor health-related quality of life. Treatment of this condition is often organ based and non-curative. However, there are newer, potentially disease-modifying therapies available to treat certain aspects of the disease. This review focuses on old and new therapies in the management of SSc in clinical practice.